EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

‘JIVANEEYAM’ - National workshop on the development of integrative protocols for the management of different cancers- A brief overview

Shivani Ghildiyal, Parvathy Venate, S. Jonah

Ayush Journal of Integrative Oncology · 2024

DOI: 10.4103/ajio.ajio_19_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ayush Journal of Integrative Oncology, 2024. Verfasst von Shivani Ghildiyal und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Jivaneeyam 2023 was a 6-day workshop for the development of integrative protocols for enhancing cancer care conducted by the Centre of Integrative Oncology (CIO) in the first 2 weeks of September 2023. It was sponsored by and conducted at All India Institute of Ayurveda, Ministry of AYUSH, Government of India, New Delhi. The Organizing Team was constituted by the Chief Patron – Prof. Tanuja Nesari, Chief Organizing Secretary – Prof. Jonah S, and Organizing Secretaries – Dr. V. G. Huddar, Dr. Shivani Ghildiyal, and Dr. Richa Tripathi. Jivaneeyam was initially organized in 2020 with the primary objective of initiating dialog and sharing clinical experiences between the experts from conventional and traditional systems of medicine for cancer care. The data compiled from the event had been compiled to develop an integrative protocol for the management of five cancers – breast cancer, lung cancer, leukemia, hepatocellular cancer, and pancreatic cancer. Jivaneeyam 2023 was taken up in continuum to revise and update these protocols. In the 6-day long workshop, each day was dedicated exclusively to the discussion and finalization of protocol pertaining to one single cancer taking suggestions from domain experts including allopathic and AYUSH practitioners. The final document will explore the trends in understanding the principles and practices in cancer management through Ayurveda and will serve as a guide to practitioners, academicians, and students working in the field of oncology, to traverse a path of integration in the best possible realms. INAUGURAL PROGRAM The inaugural ceremony was presided over by Prof. Tanuja Nesari, Director, AIIA, with Dr. Shalini Singh, Director, National Institute of Cancer Prevention and Research as the chief guest. Dr. Singh delivered a compelling address at the event, sharing her insightful views on the integration of Ayurveda into cancer care. She highlighted key areas for potential collaborative research, with a particular focus on the immense value of traditional systems in both the prevention of cancer and the revitalization of health during cancer survivorship. Her emphasis on the holistic healing capabilities of Ayurveda underscored its transformative potential in supporting cancer patients and enhancing long-term wellness. DAY 1: SEPTEMBER 4, 2023 – PROTOCOL DISCUSSION ON BREAST CANCER The expert panel was constituted by Prof. Subhash Gupta, Radiation Oncology at AIIMS (All India Institute of Medical Sciences, New Delhi); Dr. Showket Hussain, Scientist-C, NCIPR-ICMR; Dr. Vineeta Deshmukh, Professor, Sanskrit Samhita Siddhanta Department, BSDT’s Ayurved College, Wagholi, Pune; Dr. Shweta Gurjar, Assistant Director, Integrated Cancer Treatment and Research Centre, Vishwashanti Dham, Wagholi, Pune; and Dr. Kamini Diman, Associate Professor, Prasuti Tantra and Stri Roga, All India Institute of Ayurveda, New Delhi. The discussions spanned across five major areas of integration in breast cancer-chemoprevention, add-on intervention with conventional care, symptomatic management for treatment-related toxicity, palliative care, and prevention of recurrence. The major emphasis was given on primary prevention and the need for community trials for identification of risk factors and active intervention through Ayurveda active discussion on the strategy prepared was done to make changes in primary prevention, add-on therapy, advanced care, prevention of recurrence and chemo-radio-adjuvant care. Another key area for intervention is the maintenance therapy to prevent progression, especially in triple-negative breast cancer. The utility of repeated basti chikitsa followed by rasayana was mentioned. Integrative strategies for lymphedema and treatment-related osteoporosis and hot flushes were discussed. The need for psychological and sexual rehabilitation needs more intervention from integrative practices. DAY 2: SEPTEMBER 5, 2023 – PROTOCOL DISCUSSION ON LUNG CANCER Resource persons for this day were Dr. Rambha Pandey, Additional Professor, Radiation Oncology, IRCH-AIIMS; Dr. Vineeta Deshmukh, Professor, Sanskrit Samhita Siddhanta Department, BSDT’s Ayurveda College, Wagholi, Pune; Dr. Shweta Gurjar, Assistant Director, Integrated Cancer Treatment and Research Centre, Vishwashanti Dham, Wagholi, Pune; and Dr. Lima Mathew, Consultant, Saptarcchi Ayurveda Clinic, Mangalore. On presentation of the base protocol, suggestions and corrections were invited from the experts. The scope of Ayurvedic intervention in smoking de-addiction was discussed in detail. The impact of smoking and pollution on pulmonary functions and the scope of Rasayana to improve the same were discussed. Drugs such as Pippali (Piper longum), Haridra (Curcuma longa), Vasa (Adhatoda vasica), and Chyavanaprasha with proven anticancerous activity against lung cancer can be taken up for clinical trials to generate more evidence.[1-4] Loss of appetite and cancer-related cachexia were identified to adversely affect treatment prospectives and can be targeted. In operable cases, mild purgation before surgery was recommended to improve recovery. Furthermore, during ongoing chemotherapy, abhyanga (local oleation over the chest) with oils like Karpooradi taila followed by hot water fomentation can be a nonpharmacological intervention to reduce the impact of chest congestion and productive cough. The session was concluded with a discussion of incorporating Ayurvedic dietetic principles and Yoga practices to cope with and enhance the clinical outcomes during active conventional care. DAY 3: SEPTEMBER 6, 2023 – PROTOCOL DISCUSSION ON PANCREATIC CANCER Padmashri, Vd. Balendu Prakash Sir, Founder Director, VPC Cancer Research Foundation; Dr. Naman Utreja, Associate Consultant, Radiation Oncology, Fortis Hospital, New Delhi; and Dr. Lima Mathew, Consultant, Saptarcchi Ayurveda Clinic, Mangalore, were the resource persons. The prompt identification of surgical and unresectable cases is cardinal to optimize the treatment outcomes. Being an aggressive subtype with a median survival of less than a year, this is an area where integration is urgently required. Vd. Balendu Prakash shared his expertise on the preventive aspects of pancreatitis, emphasizing causative factors such as psychological stress, sleep deprivation, and unhealthy diets in the pathogenesis of pancreatic cancer.[5,6] In patients suffering from pancreatitis, periodic assessment of tumor marker CA 19.9 and abdominal ultrasonography will be beneficial as early screening. The line of management of amlapitta, gulma, grahaniroga, and vidradhi can be adopted in the management of pancreatic cancer. More research can be initiated in maintenance therapy to prevent the progression of the disease and promote health and vitality. The session concluded with recommendations for the establishment of a cancer registry for cancer patients availing Ayush interventions. This registry would help track patient data, outcomes, and treatments, ensuring a holistic approach to cancer care. DAY 4: SEPTEMBER 11, 2023 – PROTOCOL DISCUSSION ON LEUKEMIA An expert panel constituted by Vd. Tapan Kumar, Consultant, SGVP hospital, Ahmedabad; Dr. Pankaj Wanjarkhedkar, Ayurveda and Integrative Cancer Consultant at Deenanath Mangeshkar Hospital and Research Center, Pune; Dr. Sharad Porte, Associate Professor, Agad Tantra and Vidhi Vaidyak, and In Charge of Cancer Consultation and Treatment Unit, National Institute of Ayurveda; Dr. M. Gopikrishnan, Professor, SJG Ayurveda College, Koppal; and Dr. Rajgopal Krishnan, Physician, SKVA Pharmacy, Kerala. The discussion started with classifying the different etiological factors in the causation of leukemia-infectious, radiation-induced, familial, chemical-induced, and specific strategies to combat the same. The emphasis was given to work in preleukemic conditions where there is a dearth of conventional care. Drugs and formulations to improve general immunity and combat anemia and thrombocytopenia were suggested to be given along with conventional care. The utility of herbomineral preparations such as Vaidurya, Mukta, Heeraka bhasma, Ekangaveer rasa, Sameerpanag rasa, and Rudra rasa was discussed. The incorporation of calorie restriction (langhana), which has been proven to be beneficial in augmenting the chemotherapy outcomes in leukemia, can be utilized here as well.[7,8] The session ended with a suggestion of the future scope of research related to the role of Ayurveda in the prolongation of relapse and as supportive therapy in leukemia. DAY 5: SEPTEMBER 12, 2023 – PROTOCOL DISCUSSION ON HEPATOCELLULAR CANCER A discussion on the protocol for hepatocellular cancer was done. The team of experts included Dr. Durgatosh Pandey, Head-Surgical Oncology, Manipal Hospital, New Delhi; Dr. Santosh Patil, In Charge, Abuda Cancer Care Unit, KLEU Ayurveda Mahavidyalaya, Belgaum; Vd. Tapan Kumar, SGVP Hospital, Ahmedabad; Dr. Pankaj Wanjarkhedkar, Ayurveda and Integrative Cancer Consultant at Deenanath Mangeshkar Hospital and Research Center, Pune; and Dr. M. Gopikrishnan, Professor, SJG Ayurveda College, Koppal. The incorporation of Ayurveda in improving surgical outcomes was discussed. Drugs such as Kumari (Aloe vera) and Yashtimadhu (Glycyrrhiza glabra) are hepatoprotective and can hasten hepatic regeneration following resection.[9,10] More hepatoprotective and adaptogenic drugs can be given to reduce the recovery time in resectable cases, thereby facilitating the initiation of chemotherapy. The prospect of palliative care in advanced stages would be a key area for Ayurveda. The add-on intervention for symptomatic relief is another important area. Caution must be taken in prescribing herbomineral preparations and alcoholic preparations. The session ended with a discussion on the importance of dietary modifications in hepatic dysfunction. DAY 6: SEPTEMBER 13, 2023 – SUMMARY On the last day of the workshop, a summary presentation of revision to be made in protocols for breast, lung, pancreatic, leukemia, and hepatocellular cancer was done. This was agreed and finalized by the experts. The valedictory function was preceded by a guest lecture by Dr. Shekhar Kashyap, Interventional Cardiologist, AIIMS. He highlighted the importance of intermittent fasting in chronic ailments citing its effect on improving insulin sensitivity, cellular repair, immune activation, and even longevity.[11,12] This was followed by the valedictory session of the workshop with Dr. Shekhar Kashyap as the chief guest. Prof. Tanuja Nesari, Director, AIIA, appreciated the initiative of the CIO and advised to prepare robust guidelines for integrative practices which can be a useful tool for practitioners and researchers throughout India. Dr. V. G. Huddar presented the summary of the workshop. The program culminated with a vote of thanks by Dr. Shivani Ghildiyal. Jivaneeyam is an endeavor to amalgamate knowledge from diverse systems of medicine, creating an integrated approach designed to offer the highest level of benefit to patients. Through meticulous documentation and rigorous research, this effort paves the way toward establishing a holistic treatment model that can be replicated worldwide, ensuring the well-being of individuals everywhere. This collaborative vision emphasizes the importance of blending tradition and modern science, forging a path to enhanced global health. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.

Zitieren

APA

Ghildiyal, S., Venate, P., & Jonah, S. (2024). ‘JIVANEEYAM’ - National workshop on the development of integrative protocols for the management of different cancers- A brief overview. Ayush Journal of Integrative Oncology. https://doi.org/10.4103/ajio.ajio_19_24

Vancouver

Ghildiyal S, Venate P, Jonah S. ‘JIVANEEYAM’ - National workshop on the development of integrative protocols for the management of different cancers- A brief overview. Ayush Journal of Integrative Oncology. 2024. doi:10.4103/ajio.ajio_19_24

BibTeX
@article{Ghildiyal2024,
  author = {Ghildiyal, Shivani and Venate, Parvathy and Jonah, S.},
  title = {‘JIVANEEYAM’ - National workshop on the development of integrative protocols for the management of different cancers- A brief overview},
  journal = {Ayush Journal of Integrative Oncology},
  year = {2024},
  doi = {10.4103/ajio.ajio_19_24}
}
Kostenlos starten →